Whole-Body 68Ga-DOTANOC PET/MRI Versus 68Ga-DOTANOC PET/CT in Patients With Neuroendocrine Tumors: A Prospective Study in 28 Patients.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28682844)

Published in Clin Nucl Med on July 06, 2017

Authors

Dominik Berzaczy1, Chiara Giraudo, Alexander R Haug, Markus Raderer, Daniela Senn, Georgios Karanikas, Michael Weber, Marius E Mayerhoefer

Author Affiliations

1: From the Divisions of *General and Pediatric Radiology and †Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, and ‡Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.

Articles by these authors

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet (2004) 11.13

Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol Cell (2008) 7.68

Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med (2008) 7.25

Circulating microRNAs in patients with coronary artery disease. Circ Res (2010) 6.28

Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med (2014) 6.10

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med (2008) 6.08

Targets and dynamics of promoter DNA methylation during early mouse development. Nat Genet (2010) 4.27

Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens (2009) 2.68

Methylated DNA immunoprecipitation (MeDIP). Methods Mol Biol (2009) 2.17

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol (2008) 2.07

Bone marrow-derived cells contribute to infarct remodelling. Cardiovasc Res (2006) 2.00

Tumour response of osteosarcoma to neoadjuvant chemotherapy evaluated by magnetic resonance imaging as prognostic factor for outcome. Int Orthop (2014) 1.98

New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood (2008) 1.97

Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma. J Hepatol (2013) 1.95

OpenSPIM: an open-access light-sheet microscopy platform. Nat Methods (2013) 1.88

Multilayer mounting enables long-term imaging of zebrafish development in a light sheet microscope. Development (2012) 1.87

Antibiotic therapy after acute myocardial infarction: a prospective randomized study. Circulation (2003) 1.84

Tako-Tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery. Eur Heart J (2007) 1.81

Global profiling of DNA methylation erasure in mouse primordial germ cells. Genome Res (2012) 1.78

Abnormalities in intracellular Ca2+ regulation contribute to the pathomechanism of Tako-Tsubo cardiomyopathy. Eur Heart J (2009) 1.78

Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial. Hypertension (2010) 1.74

T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood (2002) 1.71

JPEG2000 compression of thin-section CT images of the lung: effect of compression ratio on image quality. Radiology (2006) 1.70

FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals. Eur J Radiol (2005) 1.70

Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis? Radiology (2009) 1.67

Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol (2003) 1.64

Electrocardiographic and further predictors for permanent pacemaker requirement after transcatheter aortic valve implantation. Europace (2010) 1.59

The comparative effects of azilsartan medoxomil and olmesartan on ambulatory and clinic blood pressure. J Clin Hypertens (Greenwich) (2011) 1.58

Activated cell survival cascade protects cardiomyocytes from cell death in Tako-Tsubo cardiomyopathy. Eur J Heart Fail (2009) 1.57

[11C] methionine and [18F] fluorodeoxyglucose PET in the follow-up of glioblastoma multiforme. J Neurooncol (2007) 1.51

Chlamydia psittaci Infection in nongastrointestinal extranodal MALT lymphomas and their precursor lesions. Am J Clin Pathol (2011) 1.49

In utero tractography of fetal white matter development. Neuroimage (2008) 1.46

CT angiography of pulmonary arteries to detect pulmonary embolism: improvement of vascular enhancement with low kilovoltage settings. Radiology (2006) 1.45

Gadobenate dimeglumine-enhanced 3.0-T MR imaging versus multiphasic 64-detector row CT: prospective evaluation in patients suspected of having pancreatic cancer. Radiology (2011) 1.43

90Y-ibritumomab tiuxetan (Zevalin) in heavily pretreated patients with mucosa associated lymphoid tissue lymphoma. Leuk Lymphoma (2010) 1.43

Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with fludarabine: effect on tumor microenvironment. Leuk Lymphoma (2011) 1.42

Epigenomics: mapping the methylome. Cell Cycle (2006) 1.42

Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Eur Heart J (2011) 1.42

Primary follicular lymphoma of the duodenum is a distinct mucosal/submucosal variant of follicular lymphoma: a retrospective study of 63 cases. J Clin Oncol (2011) 1.41

Ambulatory blood pressure monitoring after 1 year on valsartan or amlodipine-based treatment: a VALUE substudy. J Hypertens (2007) 1.39

Tako-Tsubo cardiomyopathy: NT-proBNP as a reliable parameter of a favourable prognosis? Int J Cardiol (2007) 1.39

Time-efficient CT colonography interpretation using an advanced image-gallery-based, computer-aided "first-reader" workflow for the detection of colorectal adenomas. Eur Radiol (2012) 1.38

High-speed panoramic light-sheet microscopy reveals global endodermal cell dynamics. Nat Commun (2013) 1.35

Elevated nicotianamine levels in Arabidopsis halleri roots play a key role in zinc hyperaccumulation. Plant Cell (2012) 1.33

Occult scaphoid fractures: comparison of multidetector CT and MR imaging--initial experience. Radiology (2006) 1.31

Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma. Blood (2004) 1.30

Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma. J Clin Oncol (2006) 1.30

Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial). J Am Coll Cardiol (2012) 1.28

Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients. Nephrol Dial Transplant (2011) 1.27

Mucosa-associated lymphoid tissue lymphoma: novel translocations including rearrangements of ODZ2, JMJD2C, and CNN3. Clin Cancer Res (2008) 1.25

Readout-segmented echo-planar imaging improves the diagnostic performance of diffusion-weighted MR breast examinations at 3.0 T. Radiology (2012) 1.25

Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response. Haematologica (2012) 1.25

Endurance exercise training in orthostatic intolerance: a randomized, controlled trial. Hypertension (2005) 1.25

Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine. Eur J Nucl Med Mol Imaging (2003) 1.23

Antibiotic abscess penetration: fosfomycin levels measured in pus and simulated concentration-time profiles. Antimicrob Agents Chemother (2005) 1.22

High incidence of t(11;18)(q21;q21) in Helicobacter pylori-negative gastric MALT lymphoma. Blood (2002) 1.22

Differential modulation of the default mode network via serotonin-1A receptors. Proc Natl Acad Sci U S A (2012) 1.22

Does MALT lymphoma of the lung require immediate treatment? An analysis of 11 untreated cases with long-term follow-up. Anticancer Res (2007) 1.21

Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension. J Clin Invest (2003) 1.21

US-guided 14-gauge core-needle breast biopsy: results of a validation study in 1352 cases. Radiology (2008) 1.20

A combined high temporal and high spatial resolution 3 Tesla MR imaging protocol for the assessment of breast lesions: initial results. Invest Radiol (2009) 1.17

Esophageal cancer: a critical evaluation of systemic second-line therapy. J Clin Oncol (2011) 1.17

Detectability of catheters on bedside chest radiographs: comparison between liquid crystal display and high-resolution cathode-ray tube monitors. Radiology (2004) 1.16

Exceptional early blood pressure control rates: the ACCOMPLISH trial. Blood Press (2007) 1.15

Flat-panel display (LCD) versus high-resolution gray-scale display (CRT) for chest radiography: an observer preference study. AJR Am J Roentgenol (2005) 1.15

Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging. Invest Radiol (2014) 1.14

Autoimmune thrombocytopenia in non-Hodgkin's lymphomas. Haematologica (2008) 1.14

Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET. J Nucl Med (2004) 1.12

The in vivo effects of unloading and compression on T1-Gd (dGEMRIC) relaxation times in healthy articular knee cartilage at 3.0 Tesla. Eur Radiol (2009) 1.11

Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions. J Nucl Med (2013) 1.11

Clinical applications of arterial stiffness: therapeutics and pharmacology. Am J Hypertens (2002) 1.10

Characterization of benign and malignant breast lesions with computed tomography laser mammography (CTLM): initial experience. Invest Radiol (2005) 1.10

Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI? Eur J Radiol (2010) 1.10

High efficacy of concomitant treatment of undifferentiated (anaplastic) thyroid cancer with radiation and docetaxel. J Clin Endocrinol Metab (2010) 1.10

Monoclonal immunoglobulin production is a frequent event in patients with mucosa-associated lymphoid tissue lymphoma. Clin Cancer Res (2004) 1.09

Quantitative evaluation of contrast-enhanced ultrasound after intravenous administration of a microbubble contrast agent for differentiation of benign and malignant thyroid nodules: assessment of diagnostic accuracy. Eur Radiol (2012) 1.09

Lumbar intervertebral disc abnormalities: comparison of quantitative T2 mapping with conventional MR at 3.0 T. Eur Radiol (2010) 1.08

Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study. Blood Press (2008) 1.08

Positron emission tomography with [18F] 2-fluoro-D-2- deoxyglucose in primary cutaneous T-cell lymphomas. Haematologica (2004) 1.07

Underlying autoimmune diseases are not aggravated during treatment with lenalidomide in patients with mucosa-associated lymphoid tissue lymphoma. Leuk Lymphoma (2014) 1.07

A phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma). Haematologica (2012) 1.07

Diagnostic imaging in Merkel cell carcinoma: lessons to learn from 16 cases with correlation of sonography, CT, MRI and PET. Eur J Radiol (2008) 1.06

Impact of sonography in gouty arthritis: comparison with conventional radiography, clinical examination, and laboratory findings. Eur J Radiol (2007) 1.05

Estimation of the firing distance through micro-CT analysis of gunshot wounds. Int J Legal Med (2010) 1.04

Bone microarchitecture in hemodialysis patients assessed by HR-pQCT. Clin J Am Soc Nephrol (2011) 1.04

Direct detector radiography versus dual reading computed radiography: feasibility of dose reduction in chest radiography. Eur Radiol (2006) 1.03

Mechanisms of DNA methylation and demethylation in mammals. Biochimie (2012) 1.02

Palliative chemotherapy for recurrent and metastatic esophageal cancer. Anticancer Res (2007) 1.02

Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study. J Clin Oncol (2002) 1.02

Whole-body MRI and PET-CT in the management of cancer patients. Eur Radiol (2006) 1.01

Dynamic regulation of DNA methylation during mammalian development. Epigenomics (2009) 1.01

The prenatal origin of hemispheric asymmetry: an in utero neuroimaging study. Cereb Cortex (2010) 1.00

Lossy three-dimensional JPEG2000 compression of abdominal CT images: assessment of the visually lossless threshold and effect of compression ratio on image quality. Radiology (2007) 1.00

Thromboembolic events during treatment with thalidomide. Blood (2002) 1.00

Mosaicism due to myeloid lineage restricted loss of heterozygosity as cause of spontaneous Rh phenotype splitting. Blood (2007) 1.00

Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer. Clin Cancer Res (2007) 1.00

Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of the head and neck area: high rate of disease recurrence following local therapy. Cancer (2003) 1.00

Detection of histologically proven peritoneal carcinomatosis with fused 18F-FDG-PET/MDCT. Eur J Radiol (2008) 1.00

Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients. Am J Med (2013) 0.99